BHVN
Biohaven Ltd.NYSEHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.42B
P/E Ratio
—
EPS
$-5.57
Beta
3.31
52W High
$18.57
52W Low
$7.48
50-Day MA
$9.44
200-Day MA
$11.90
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Biohaven Ltd.
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders in the United States. The company is headquartered in New Haven, Connecticut.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-607.19M |
| Operating Margin | 0.00% |
| Return on Equity | -333.00% |
| Return on Assets | -83.40% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.86 |
| Price-to-Book | 10.99 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.19 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $150.56M |
| Float | $124.00M |
| % Insiders | 11.08% |
| % Institutions | 97.53% |
Historical Volatility
HV 10-Day
68.37%
HV 20-Day
60.98%
HV 30-Day
71.50%
HV 60-Day
69.88%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($21.71 target)
4
Strong Buy10
Buy5
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026